{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Gunesch S"],"funding":["Mass Spectrometry Core of the Salk Institute","Bavaria California Technology Center","NIH","Federal Ministry of Education and Research","NIH HHS"],"pagination":["101378"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6928325"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["29"],"pubmed_abstract":["Alzheimer's disease (AD) is a multifactorial disease and the most common form of dementia. There are no treatments to cure, prevent or slow down the progression of the disease. Natural products hold considerable interest for the development of preventive neuroprotectants to treat neurodegenerative disorders like AD, due to their low toxicity and general beneficial effects on human health with their anti-inflammatory and antioxidant features. In this work we describe regioselective synthesis of 7-O-ester hybrids of the flavonoid taxifolin with the phenolic acids cinnamic and ferulic acid, namely 7-O-cinnamoyltaxifolin and 7-O-feruloyltaxifolin. The compounds show pronounced overadditive neuroprotective effects against oxytosis, ferroptosis and ATP depletion in the murine hippocampal neuron "],"journal":["Redox biology"],"pubmed_title":["7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo."],"pmcid":["PMC6928325"],"funding_grant_id":["R41 AI104034","1S10OD021815-01","RO1 AG046153","P30 014195","S10 OD021815","RF1 AG054714"],"pubmed_authors":["Pinto AFM","Maurice T","Gunesch S","Hoffmann M","Kiermeier C","Decker M","Fischer W","Maher P"],"additional_accession":[]},"is_claimable":false,"name":"7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo.","description":"Alzheimer's disease (AD) is a multifactorial disease and the most common form of dementia. There are no treatments to cure, prevent or slow down the progression of the disease. Natural products hold considerable interest for the development of preventive neuroprotectants to treat neurodegenerative disorders like AD, due to their low toxicity and general beneficial effects on human health with their anti-inflammatory and antioxidant features. In this work we describe regioselective synthesis of 7-O-ester hybrids of the flavonoid taxifolin with the phenolic acids cinnamic and ferulic acid, namely 7-O-cinnamoyltaxifolin and 7-O-feruloyltaxifolin. The compounds show pronounced overadditive neuroprotective effects against oxytosis, ferroptosis and ATP depletion in the murine hippocampal neuron ","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Jan","modification":"2025-04-04T20:43:42.066Z","creation":"2020-05-22T07:53:04Z"},"accession":"S-EPMC6928325","cross_references":{"pubmed":["31926632"],"doi":["10.1016/j.redox.2019.101378"]}}